Kolexia
Joris Magalie Hématologie
Joris Magalie
Hématologie
Centre Hospitalier D'Amiens Salouël Site Sud
Salouël, France
86 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Lymphome B diffus à grandes cellules Syndromes myélodysplasiques Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie myélomonocytaire chronique

Collaborateurs

Voir plus
Houot Roch
Houot Roch
Hôpital Pontchaillou, Rennes, France
Morschhauser Franck
Morschhauser Franck
Centre Hospitalier de Lille, Lille, France
Gastinne Thomas
Gastinne Thomas
Hôpital Hôtel-Dieu Nantes, Nantes, France
Bachy Emmanuel
Bachy Emmanuel
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Pfizer
3 collaboration(s)
Dernière en 2023
Gilead
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood   07 mars 2024
Outcomes of Patients With Aggressive B-Cell Lymphoma After Failure of ...
Medscape   27 janvier 2024
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
The Occurrence of Infection and TP53 Mutation Are Risk Factors for Cardiovascular Toxicity of Acute Myeloid Leukemia Induction Therapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood advances   01 novembre 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nature medicine   31 octobre 2023
Outcomes of Patients With Aggressive B-Cell Lymphoma After Failure of ...
Medscape   31 octobre 2023